PATENT CLAIM ANALYSIS

Application Number: 15879740
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["424", "464000"]

Abstract:
The present invention relates to a lozenge dosage form.

Claim (Index 5):
The lozenge dosage form of  claim 4 , wherein the disintegrative tablet portion comprises two layers, wherein a first layer comprises a first pharmaceutically active ingredient, and wherein a second layer comprises a second pharmaceutically active ingredient.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15293535', '15795846', '15795476', '15181462', '12566078']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7205114616175766
- 35 USC 102 Novelty (BERT): 0.4947313071829718
- Combined Prediction Score: 0.6979334461741161
- Mean Citation Score: 171.172608
- Max Citation Score: 179.59795
- Similarity Product: 114.05320691047012

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test